Phase 1b MMV367 PK/PD and Safety in Healthy Adult Volunteers Experimentally Infected With Blood Stage P. Falciparum

Conditions:   Infections;   Vector Borne Diseases;   Systemic Inflammatory Response Syndrome;   Inflammation;   Pathologic Processes;   Malaria;   Malaria,Falciparum;   Parasitemia;   Parasitic Diseases;   Protozoan Infections;   Antimalarials;   Anti-Infective Agents Interventions:   Drug: MMV367;   Other: P. falciparum IBSM infection Sponsors:   Medicines for Malaria Venture;   GlaxoSmithKline;   Southern Star Research Pty Ltd.;   ICON plc;   University of the Sunshine Coast;   QIMR Berghofer Medical Research Institute;   Queensland Paediatric Infectious Diseases (QPID) laboratory;   Swiss BioQuant A.G., Switze rland Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials